Co-Avox Indications/Uses

Co-amoxiclav is indicated for the treatment of the following infections caused by susceptible pathogens: lower respiratory tract infections, acute otitis media, sinusitis, urinary tract infections, skin and tissue infections. Co-amoxiclav is also indicated for bacterial infections likely to be caused by amoxicillin-resistant beta-lactamase producing strains and that treatment should not usually exceed 14 days. It is also considered for the following conditions: Recurrent tonsillitis; Acute exacerbations of chronic bronchitis, bronchopneumonia; Urinary tract infection especially recurrent and complicated but not prostatitis; Septic abortion, pelvic or puerperal sepsis & intra-abdominal sepsis; Cellulitis, animal bites and several dental abscess with spreading cellulitis.
To treat following condition: Lower respiratory tract infections, acute bacterial otitis media, sinusitis - caused by beta-lactamase-producing isolates of Haemophilus influenzae and Moraxella catarrhalis.
Skin and skin structure infections caused by beta-lactamase-producing isolates of Staphylococcus aureus, Escherichia coli, Klebsiella species.
Urinary tract infections caused by beta-lactamase-producing isolates of E. coli, Klebsiella species, and Enterobacter species.